Study of Safety and Efficacy of MY008211A in Paroxysmal Nocturnal Hemoglobinuria (PNH) Patients Who Are Naive to Complement Inhibitor Therapy

Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2025
The main purpose of this study is to evaluate the efficacy of MY008211A compared to eculizumab in PNH patients.
Epistemonikos ID: f3a493a2ea446b19f41989845819669713d58664
First added on: Apr 18, 2025